期刊文献+

LncRNA HULC在神经胶质瘤中的表达和临床意义 被引量:1

The expression and clinical significances of long non-coding RNA HULC in human gliomas
原文传递
导出
摘要 目的研究神经胶质瘤中长链非编码RNA肝癌高表达转录本(highly up-regulated in liver cancer,HULC)的表达以及临床意义,探讨选择其作为神经胶质瘤标志物的可能性。方法应用red time PCR技术检测30例神经胶质瘤标本中HULC表达,分析HULC表达水平随神经胶质瘤病理级别以及血管内皮生长因子(VEGF)和肿瘤新生微血管密度(MVD)表达之间的关系。结果神经胶质瘤病理组织中HULC表达水平随神经胶质瘤恶性程度增高而增高,与肿瘤病理级别(WHO-II、WHO-III和WHO-IV)呈正相关(P<0.05),与MVD和VEGF表达呈正相关(r=0.516,r=0.515,P<0.05)。结论 HULC表达与神经胶质瘤恶性程度和血管生成密度相关,可作为潜在的肿瘤标志物为临床诊断提供依据。 Objective To investigate the expression and clinical significances of long non-coding RNA HULC in hunman gliomas and its potential for clinical diagnosis. Methods The expression of HULC was measured by realtime PCR assay and the relationship between the expression of HULC and pathological grade, VEGF and MVD in human gliomas were analysed in 30 patients with gliomas. Results The expression of HULC was increased with malignant grade, positive correlation with the grade of gliomas (WHO-II, WHO-III and WHO-IV)(P〈0.05) and the level of MVD and VEGF (r=0.516, r=0.515, P〈 0.05 ). Conclusion The expression of HULC was correlation with the grade of gliomas and angiogenesis, it may be a potential marker for clinical diagnosis.
出处 《中国城乡企业卫生》 2016年第9期10-12,共3页 Chinese Journal of Urban and Rural Enterprise Hygiene
基金 国家自然科学基金青年项目:(31501159)
关键词 神经胶质瘤 长链非编码RNA HULC 血管生成 Glioma Long non-coding RNA HULC Angiogenesis
  • 相关文献

参考文献14

  • 1Tang H,Liu Q,Liu X,et al.Plasma miR-185 as a predictive biomarker for prognosis of malignant glioma [J].J Cancer Res Ther, 2015,11(3) : 630-634.
  • 2Wang Y,Wang Y,Li J,et al.CRNDE,a long-noncoding RNA,pro- motes glioma cell growth and invasion through mTOR signaling[J]. Cancer Lett, 2015,367(2) : 122-128.
  • 3Lu Z,Xiao Z,Liu F,et al.Long non-coding RNA HULC promotes tu- mor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 ( SPHK1 )[J].Oncotarget, 2015,7(1) : 241-254.
  • 4Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classifica- tion of turnouts of the central nervous system. Acta Neuropathol, 2007, 114(2):97-109.
  • 5Li C, Chen J, Zhang K, et al. Progress and Prospects of Long Non- coding RNAs(lncRNAs ) in Hepatocellular Carcinoma[J]. Cell Physiol Biochem, 2015,36( 2 ) : 423-434.
  • 6Zhao J, Fan Y, Wang K, et al. LncRNA HULC affects the diffel~nti- ation of Treg in HBV-related liver cirrhosis[J].Int Immunopharmacol, 2015,28(2) :901-905.
  • 7Yang Z, Lu Y, Xu Q, et al. HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy:A Preliminary Analysis from Gene Ex- pression Omnibus[J].Dis Markers, 2015,2015 : 191029.
  • 8Peng W, Gao W, Feng J. Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer[J]. Med Oncol,2014,31 (12) : 346.
  • 9Shi S, Li X, You B, et al. High Expression of FGFR4 Enhances Tu- mor Growth and Metastasis in Nasopharyngeal Carcinoma [J]. J Can- cer,2015,6(12) : 1245-1254.
  • 10Deng Z, Zhou J, Hart X, et al. TCEB2 confers resistance to VEGF targeted therapy in ovarian cancer[J]. Oncol Rep, 2015,35 ( 1 ) : 359- 365.

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部